SG10201700204TA - Mixed disulfide conjugates of thienopyridine compounds and uses thereof - Google Patents

Mixed disulfide conjugates of thienopyridine compounds and uses thereof

Info

Publication number
SG10201700204TA
SG10201700204TA SG10201700204TA SG10201700204TA SG10201700204TA SG 10201700204T A SG10201700204T A SG 10201700204TA SG 10201700204T A SG10201700204T A SG 10201700204TA SG 10201700204T A SG10201700204T A SG 10201700204TA SG 10201700204T A SG10201700204T A SG 10201700204TA
Authority
SG
Singapore
Prior art keywords
mixed disulfide
disulfide conjugates
thienopyridine compounds
thienopyridine
compounds
Prior art date
Application number
SG10201700204TA
Inventor
Haoming Zhang
Paul Hollenberg
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of SG10201700204TA publication Critical patent/SG10201700204TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
SG10201700204TA 2013-01-09 2014-01-06 Mixed disulfide conjugates of thienopyridine compounds and uses thereof SG10201700204TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361750633P 2013-01-09 2013-01-09

Publications (1)

Publication Number Publication Date
SG10201700204TA true SG10201700204TA (en) 2017-03-30

Family

ID=51167312

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201505283RA SG11201505283RA (en) 2013-01-09 2014-01-06 Mixed disulfide conjugates of thienopyridine compounds and uses thereof
SG10201700204TA SG10201700204TA (en) 2013-01-09 2014-01-06 Mixed disulfide conjugates of thienopyridine compounds and uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201505283RA SG11201505283RA (en) 2013-01-09 2014-01-06 Mixed disulfide conjugates of thienopyridine compounds and uses thereof

Country Status (14)

Country Link
US (2) US9718778B2 (en)
EP (1) EP2943482B1 (en)
JP (2) JP6072938B2 (en)
KR (1) KR101841332B1 (en)
CN (1) CN105051025B (en)
AU (1) AU2014205629B2 (en)
CA (1) CA2897407C (en)
DK (1) DK2943482T3 (en)
HK (1) HK1218748A1 (en)
IL (1) IL239823B (en)
MX (1) MX2015008877A (en)
NZ (1) NZ709744A (en)
SG (2) SG11201505283RA (en)
WO (1) WO2014109987A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016176644A1 (en) 2015-04-30 2016-11-03 The Regents Of The University Of Michigan Mixed disulfide conjugates of thienopyridine compounds and uses thereof
JP2021511800A (en) * 2018-01-31 2021-05-13 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Method for synthesizing a mixed disulfide bond of a biocatalyst and a thienopyridine compound
US11642335B2 (en) * 2019-09-26 2023-05-09 Board Of Regents, The University Of Texas System Chemical synthesis of clopidogrel active metabolites and disulfide conjugate prodrugs
WO2021070200A2 (en) * 2019-10-08 2021-04-15 Ipca Laboratories Limited Stable compositions of (7as,2's)-2-oxoclopidogrel and its pharmaceutical salts
CN111484446A (en) * 2020-04-02 2020-08-04 北京翼方生物科技有限责任公司 Clopidogrel metabolic active body disulfide derivative, preparation method and medical application thereof
CN112851570A (en) * 2021-01-13 2021-05-28 北京沃邦医药科技有限公司 Preparation method and medical application of unsaturated cyclic amine cysteine disulfide derivative
CN112812098A (en) * 2021-01-13 2021-05-18 北京沃邦医药科技有限公司 Preparation method and medical application of unsaturated cyclic amine pyridine disulfide derivative
CN115260086A (en) * 2022-09-28 2022-11-01 吉林大学 Fluoro internal standard substance and application and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
KR100567950B1 (en) * 1998-02-27 2006-04-05 상꾜 가부시키가이샤 Cyclic amino compounds
US7205404B1 (en) 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
JP2001131067A (en) 1999-08-26 2001-05-15 Sankyo Co Ltd Platelet coagulation inhibitor and arteriosclerosis- evolving inhibitor
US6710058B2 (en) * 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
JP4749702B2 (en) * 2003-11-28 2011-08-17 第一三共株式会社 Cyclic amine derivatives having a heteroaryl ring
AU2006250335B2 (en) * 2005-05-27 2010-09-02 Daiichi Sankyo Company, Limited Cyclic amine derivative having substituted alkyl group
JP2008156343A (en) * 2006-11-27 2008-07-10 Daiichi Sankyo Co Ltd Pharmaceutical composition comprising cyclic amine derivative with substituted alkyl group

Also Published As

Publication number Publication date
CA2897407C (en) 2018-05-08
CN105051025A (en) 2015-11-11
US20170334853A1 (en) 2017-11-23
KR101841332B1 (en) 2018-03-22
JP2017081968A (en) 2017-05-18
MX2015008877A (en) 2015-12-07
IL239823A0 (en) 2015-08-31
IL239823B (en) 2020-04-30
KR20150096770A (en) 2015-08-25
CN105051025B (en) 2018-06-01
NZ709744A (en) 2016-10-28
AU2014205629B2 (en) 2016-12-22
JP2016511229A (en) 2016-04-14
EP2943482B1 (en) 2019-03-13
EP2943482A4 (en) 2016-07-06
US10196356B2 (en) 2019-02-05
HK1218748A1 (en) 2017-03-10
EP2943482A1 (en) 2015-11-18
CA2897407A1 (en) 2014-07-17
US9718778B2 (en) 2017-08-01
WO2014109987A1 (en) 2014-07-17
AU2014205629A1 (en) 2015-07-23
US20150353492A1 (en) 2015-12-10
JP6072938B2 (en) 2017-02-01
DK2943482T3 (en) 2019-04-15
SG11201505283RA (en) 2015-08-28

Similar Documents

Publication Publication Date Title
IL274355B (en) Aza-pyridone compounds and uses thereof
IL241193A0 (en) Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
IL244850B (en) Stabilized efinaconazole compositions and uses thereof
EP2961779A4 (en) Polyethylene processes and compositions thereof
HK1216175A1 (en) Therapeutic compounds and compositions
EP2953474A4 (en) Compositions and methods
HK1214171A1 (en) Cenicriviroc compositions and methods of making and using the same
HK1218748A1 (en) Mixed disulfide conjugates of thienopyridine compounds and uses thereof
EP2964235A4 (en) Antimicrobial-antibiofilm compositions and methods of use thereof
SG11201507158WA (en) Stabilized polymer compositions and methods of making same
HK1220920A1 (en) Therapeutic compositions and uses thereof
GB201321693D0 (en) Composition and uses thereof
GB201323008D0 (en) Compounds and uses thereof
HUE062176T2 (en) Fertilizer compositions and methods of making and using the same
SG11201602258WA (en) Slow-release conjugates of sn-38
HK1251855A1 (en) Mixed disulfide conjugates of thienopyridine compounds and uses thereof
GB201307233D0 (en) Compounds and uses thereof
EP2964610A4 (en) Vinylsulfone-based 18f-labeling compositions and methods and uses thereof
HK1223307A1 (en) Novel compounds and uses thereof
HK1222560A1 (en) Anti-influenza compositions and methods
KR102216470B9 (en) Composition of Natural Substance
HK1223909A1 (en) Mesitylene sulfonate compositions and methods thereof
HK1210080A1 (en) Sulfate of 5-hydroxy-1h-imidazole-4-carboxamide 5--1h--4-
GB201308242D0 (en) Compositions and uses thereof
GB201319917D0 (en) Accelerator Compositions and Methods